BioForce Issued U.S. Patent for NanoArrayer Technology

BioForce Nanosciences (Ames, IA) is pleased to announce the issuing by the United States Patent and Trade Office of patent number 6,998,228. The patent is entitled "Method and apparatus for solid state molecular analysis".

Dr. Curtis Mosher, Vice President of Research and Development at BioForce and one of the co-authors of this patent stated "In general terms this patent covers a method used to create ultraminiaturized

molecular domains on chips. The process described in the patent creates bioanalytical tests that require very small amounts of sample. These tests could be extremely useful in the search for new drugs, and in minimally invasive evaluation of a person's health. Moreover, this method creates the opportunity for rapid screening of many hundreds of molecular species on a single chip requiring less than one drop of

blood."

Dr. Eric Henderson, Founder and CEO of BioForce Nanosciences, is the primary author of this patent. Dr. Henderson was quoted saying "This patent nicely rounds out a key portion of our intellectual property portfolio. One of the four pillars of the Company is our ability to follow through with innovative concepts from initial invention to commercialization. A technology development company like BioForce depends upon a strong patent portfolio to underpin its ability to successfully introduce and protect its products in the marketplace. We are pleased to see this patent issue and will continue to pursue additional patents as we build our business and establish ourselves as the practical nanotechnology company."

Visit www.bioforcenano.com